ArticlePharmaceutics2022

Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study.

Yueh-Hsiang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.